• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

State of the Industry 2010: patient-centered medical homes through 2013

Article

State of the Industry survey results

With so many stakeholders taking a long look at so many models, Edwina Rogers, executive director of the Patient-Centered Primary Care Collaborative, was surprised that most respondents (39.1%) predict that projects will spread only into a few small areas.

"I would say that's on the low side with all the activity going on," says Rogers.

Although many note medical homes can increase utilization, Rogers believes the evidence coming out of real-world applications supports the model's potential.

"It tackles the cost and quality issues, and it revamps the delivery system," she says. "It is a major component that is proven to work. We don't have any negative examples."

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.